Quick swab test could prevent newborn sepsis
NCT ID NCT03371056
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new rapid test (InSPIRe kit) that uses a simple vaginal swab to detect bacteria and infection markers in pregnant women. The goal is to quickly identify women who might pass harmful bacteria to their babies during birth, so doctors can prevent newborn infections. Over 2,500 pregnant women took part, and the test was compared to standard lab methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
InSPIRe kit (rapid diagnostic test)
What this could lead to
If successful, this test could help doctors quickly identify pregnant women carrying harmful bacteria, allowing early treatment to prevent infections in newborns.
What could go wrong
This is a completed study validating a diagnostic tool, not a treatment. The test may not be widely adopted or may not improve outcomes in real-world settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL INFECTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hopital Bichat
Paris, 75018, France
-
Hopital Louis Mourier
Colombes, 92700, France
-
Hôpital Cochin
Paris, 75014, France